01:41 PM EST, 01/16/2025 (MT Newswires) -- The US Food and Drug Administration said Thursday it has authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application pathway following an extensive scientific review.

The FDA said this is the first time the agency has authorized products commonly referred to as nicotine pouches.

"To receive marketing authorizations, the FDA must have sufficient evidence that the new products offer greater benefits to population health than risks," said Matthew Farrelly, director of the Office of Science in the FDA's Center for Tobacco Products.

"In this case, the data show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products."

In the US, the products are marketed by Swedish Match, a subsidiary of Philip Morris International ( PM ) .

Philip Morris ( PM ) didn't immediately respond to MT Newswires' request for comment.

Price: 119.17, Change: +0.66, Percent Change: +0.56